Adavosertib and Gemcitabine in Advanced Pancreatic

Clinical trial NCT05212025 · WITHDRAWN

Trial details

NCT number: NCT05212025
Sponsor: James Cleary, MD, PhD
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2022-06-01
Primary completion: 2023-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.